These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2106688)

  • 1. Diagnosis of von Willebrand disease.
    Abildgaard CF
    Prog Clin Biol Res; 1990; 324():263-8. PubMed ID: 2106688
    [No Abstract]   [Full Text] [Related]  

  • 2. Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH.
    Mazurier C; Meyer D
    Thromb Haemost; 1996 Aug; 76(2):270-4. PubMed ID: 8865544
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular mechanism and classification of von Willebrand disease.
    Sadler JE; Matsushita T; Dong Z; Tuley EA; Westfield LA
    Thromb Haemost; 1995 Jul; 74(1):161-6. PubMed ID: 8578450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In memory of Erik Jorpes. von Willebrand's disease from 1926-1983.
    Nilsson IM
    Scand J Haematol Suppl; 1984; 40():21-43. PubMed ID: 6433454
    [No Abstract]   [Full Text] [Related]  

  • 5. Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):397-420. PubMed ID: 17000885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. von Willebrand disease masquerading as haemophilia A.
    Mazurier C
    Thromb Haemost; 1992 Apr; 67(4):391-6. PubMed ID: 1631785
    [No Abstract]   [Full Text] [Related]  

  • 7. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M
    Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of heterozygotes for recessive von Willebrand's disease by the assay of antihemophilic-factor-like antigen.
    Veltkamp JJ; van Tilburg NH
    N Engl J Med; 1973 Oct; 289(17):882-5. PubMed ID: 4542316
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessment of the correlation between the von Willebrand Factor activity, the PFA-100, and the bleeding time in patients with von Willebrand disease.
    Nitu-Whalley IC; Lee CA; Hermans C
    Thromb Haemost; 2001 Aug; 86(2):715-6. PubMed ID: 11522030
    [No Abstract]   [Full Text] [Related]  

  • 11. [Von Willebrand disease: a common and unrecognized bleeding disorder].
    Boehlen F; Robert-Ebadi H; de Moerloose P
    Rev Med Suisse; 2007 Feb; 3(97):346-50. PubMed ID: 17370733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand disease, type 2B: A diagnosis more elusive than previously thought.
    Favaloro EJ
    Thromb Haemost; 2008 Mar; 99(3):630-1; author reply 632-3. PubMed ID: 18327414
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease.
    Gallinaro L; Sartorello F; Pontara E; Cattini MG; Bertomoro A; Bartoloni L; Pagnan A; Casonato A
    Thromb Haemost; 2006 Dec; 96(6):711-6. PubMed ID: 17139363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetics of von Willebrand disease.
    Mazurier C; Ribba AS; Gaucher C; Meyer D
    Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between heterozygous dominant and recessive von Willebrand's disease type I expressed by bleeding symptoms and combinations of factor VIII variables.
    Wahlberg TB; Blombäck M; Ruggeri ZM
    Thromb Haemost; 1983 Dec; 50(4):864-8. PubMed ID: 6420925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological diagnosis of Von Willebrand disease and its difficulties].
    Znazen R; Guermazi S; Karoui M
    Tunis Med; 2007 Jun; 85(6):445-9. PubMed ID: 17644894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [von Willebrand disease].
    Meyer D; Chassigneux J
    Rev Prat; 1989 Dec; 39(30):2679-83. PubMed ID: 2515582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van Vliet HH
    Acta Haematol; 2009; 121(2-3):85-97. PubMed ID: 19506353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
    Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.